Proactive tobacco treatment offering free nicotine replacement therapy and telephone counselling for socioeconomically disadvantaged smokers: a randomised clinical trial
Authors:
Open Access
Abstract
Background Evidenced-based tobacco cessation treatments are underused, especially by socioeconomically disadvantaged smokers. This contributes to widening socioeconomic disparities in tobacco-related morbidity and mortality. Methods The Offering Proactive Treatment Intervention trial tested the effects of a proactive outreach tobacco treatment intervention on population-level smoking abstinence and tobacco treatment use among a population-based sample of socioeconomically disadvantaged smokers. Current smokers (n=2406), regardless of interest in quitting, who were enrolled in the Minnesota Health Care Programs, the state's publicly funded healthcare programmes for low-income populations, were randomly assigned to proactive outreach or usual care. The intervention comprised proactive outreach (tailored mailings and telephone calls) and free cessation treatment (nicotine replacement therapy and intensive, telephone counselling). Usual care comprised access to a primary care physician, insurance coverage of Food and Drug Administration-approved smoking cessation medications, and the state's telephone quitline. The primary outcome was self-reported 6-month prolonged smoking abstinence at 1 year and was assessed by follow-up survey. Findings The proactive intervention group had a higher prolonged abstinence rate at 1 year than usual care (16.5% vs 12.1%, OR 1.47, 95% CI 1.12 to 1.93). The effect of the proactive intervention on prolonged abstinence persisted in selection models accounting for non-response. In analysis of secondary outcomes, use of evidence-based tobacco cessation treatments were significantly greater among proactive outreach participants compared with usual care, particularly combination counselling and medications (17.4% vs 3.6%, OR 5.69, 95% CI 3.85 to 8.40). Interpretation Population-based proactive tobacco treatment increases engagement in evidence-based treatment and is effective in long-term smoking cessation among socioeconomically disadvantaged smokers. Findings suggest that dissemination of population-based proactive treatment approaches is an effective strategy to reduce the prevalence of smoking and socioeconomic disparities in tobacco use. Trial registration number NCT01123967.Keywords
This publication has 28 references indexed in Scilit:
- Socioeconomic status and smoking: a reviewAnnals of the New York Academy of Sciences, 2011
- Offering Population-Based Tobacco Treatment in a Healthcare SettingAmerican Journal of Preventive Medicine, 2011
- Insights into social disparities in smoking prevalence using Mosaic, a novel measure of socioeconomic status: an analysis using a large primary care datasetBMC Public Health, 2010
- Selection and pattern-mixture models2008
- Racial/Ethnic Disparities in the Use of Nicotine Replacement Therapy and Quit Ratios in Lifetime Smokers Ages 25 to 44 YearsCancer Epidemiology, Biomarkers & Prevention, 2008
- Barriers to the Provision of Smoking Cessation Services Reported by Clinicians in Underserved CommunitiesThe Journal of the American Board of Family Medicine, 2007
- Measures of abstinence in clinical trials: issues and recommendationsNicotine & Tobacco Research, 2003
- Biochemical verification of tobacco use and cessationNicotine & Tobacco Research, 2002
- Evaluating the public health impact of health promotion interventions: the RE-AIM framework.American Journal of Public Health, 1999
- The Contemplation Ladder: Validation of a measure of readiness to consider smoking cessation.Health Psychology, 1991